Apyx Medical Corporation provided preliminary revenue guidance for the fourth quarter and full year ended December 31, 2023. For the quarter, total revenue in a range of approximately $14.2 million to $14.6 million, representing growth of 13% to 16% year-over-year.

For the full year, total revenue in a range of approximately $51.9 million to $52.3 million, representing growth of 17% to 18% year-over-year.